Combined effect of rebamipide and ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells

Shunji Hayashi, Toshiro Sugiyama, Kenji Yokota, Hiroshi Isogai, Emiko Isogai, Hirofumi Shimomura, Keiji Oguma, Masahiro Asaka, Yoshikazu Hirai

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Helicobacter pylori is a major etiological agent in gastroduodenal disorders. The adhesion of H. pylori to gastric epithelial cells is the initial step of H. pylori infection. Inhibition of H. pylori adhesion is thus a therapeutic target in the prevention of H. pylori infection. We have reported that rebamipide and ecabet sodium, mucoprotective antiulcer agents, independently inhibit H. pylori adhesion. However, the antiadhesion activity of each antiulcer agent was incomplete. Experiments were performed to evaluate the combined effect of rebamipide and ecabet sodium on H. pylori adhesion to gastric epithelial cells. MKN-28 and MKN-45 cells, derived from human gastric carcinomas, were used as target cells. Twelve clinical isolates of H. pylori were used in this study. We evaluated the effects of rebamipide and ecabet sodium, individually and in combination, on H. pylori adhesion to target cells quantitatively using our previously established enzyme-linked immunosorbent assay. Rebamipide and ecabet sodium each partially inhibited H. pylori adhesion. In contrast, adhesion was almost completely inhibited by pretreating target cells and H. pylori with the combination of rebamipide and ecabet sodium. Our studies suggest that the synergistic antiadhesion activity of rebamipide and ecabet sodium is greater than that of each antiulcer agent alone.

Original languageEnglish
Pages (from-to)557-562
Number of pages6
JournalMicrobiology and Immunology
Volume44
Issue number7
Publication statusPublished - 2000

Fingerprint

Helicobacter pylori
Stomach
Epithelial Cells
Helicobacter Infections
ecabet
rebamipide
Enzyme-Linked Immunosorbent Assay
Carcinoma

Keywords

  • Combination
  • Ecabet sodium
  • Helicobacter pylori adhesion
  • Rebamipide

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Microbiology (medical)
  • Microbiology

Cite this

Hayashi, S., Sugiyama, T., Yokota, K., Isogai, H., Isogai, E., Shimomura, H., ... Hirai, Y. (2000). Combined effect of rebamipide and ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells. Microbiology and Immunology, 44(7), 557-562.

Combined effect of rebamipide and ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells. / Hayashi, Shunji; Sugiyama, Toshiro; Yokota, Kenji; Isogai, Hiroshi; Isogai, Emiko; Shimomura, Hirofumi; Oguma, Keiji; Asaka, Masahiro; Hirai, Yoshikazu.

In: Microbiology and Immunology, Vol. 44, No. 7, 2000, p. 557-562.

Research output: Contribution to journalArticle

Hayashi, S, Sugiyama, T, Yokota, K, Isogai, H, Isogai, E, Shimomura, H, Oguma, K, Asaka, M & Hirai, Y 2000, 'Combined effect of rebamipide and ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells', Microbiology and Immunology, vol. 44, no. 7, pp. 557-562.
Hayashi, Shunji ; Sugiyama, Toshiro ; Yokota, Kenji ; Isogai, Hiroshi ; Isogai, Emiko ; Shimomura, Hirofumi ; Oguma, Keiji ; Asaka, Masahiro ; Hirai, Yoshikazu. / Combined effect of rebamipide and ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells. In: Microbiology and Immunology. 2000 ; Vol. 44, No. 7. pp. 557-562.
@article{7f20bc61121543fdb1d29fcd4c369a44,
title = "Combined effect of rebamipide and ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells",
abstract = "Helicobacter pylori is a major etiological agent in gastroduodenal disorders. The adhesion of H. pylori to gastric epithelial cells is the initial step of H. pylori infection. Inhibition of H. pylori adhesion is thus a therapeutic target in the prevention of H. pylori infection. We have reported that rebamipide and ecabet sodium, mucoprotective antiulcer agents, independently inhibit H. pylori adhesion. However, the antiadhesion activity of each antiulcer agent was incomplete. Experiments were performed to evaluate the combined effect of rebamipide and ecabet sodium on H. pylori adhesion to gastric epithelial cells. MKN-28 and MKN-45 cells, derived from human gastric carcinomas, were used as target cells. Twelve clinical isolates of H. pylori were used in this study. We evaluated the effects of rebamipide and ecabet sodium, individually and in combination, on H. pylori adhesion to target cells quantitatively using our previously established enzyme-linked immunosorbent assay. Rebamipide and ecabet sodium each partially inhibited H. pylori adhesion. In contrast, adhesion was almost completely inhibited by pretreating target cells and H. pylori with the combination of rebamipide and ecabet sodium. Our studies suggest that the synergistic antiadhesion activity of rebamipide and ecabet sodium is greater than that of each antiulcer agent alone.",
keywords = "Combination, Ecabet sodium, Helicobacter pylori adhesion, Rebamipide",
author = "Shunji Hayashi and Toshiro Sugiyama and Kenji Yokota and Hiroshi Isogai and Emiko Isogai and Hirofumi Shimomura and Keiji Oguma and Masahiro Asaka and Yoshikazu Hirai",
year = "2000",
language = "English",
volume = "44",
pages = "557--562",
journal = "Microbiology and Immunology",
issn = "0385-5600",
publisher = "Center for Academic Publications Japan",
number = "7",

}

TY - JOUR

T1 - Combined effect of rebamipide and ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells

AU - Hayashi, Shunji

AU - Sugiyama, Toshiro

AU - Yokota, Kenji

AU - Isogai, Hiroshi

AU - Isogai, Emiko

AU - Shimomura, Hirofumi

AU - Oguma, Keiji

AU - Asaka, Masahiro

AU - Hirai, Yoshikazu

PY - 2000

Y1 - 2000

N2 - Helicobacter pylori is a major etiological agent in gastroduodenal disorders. The adhesion of H. pylori to gastric epithelial cells is the initial step of H. pylori infection. Inhibition of H. pylori adhesion is thus a therapeutic target in the prevention of H. pylori infection. We have reported that rebamipide and ecabet sodium, mucoprotective antiulcer agents, independently inhibit H. pylori adhesion. However, the antiadhesion activity of each antiulcer agent was incomplete. Experiments were performed to evaluate the combined effect of rebamipide and ecabet sodium on H. pylori adhesion to gastric epithelial cells. MKN-28 and MKN-45 cells, derived from human gastric carcinomas, were used as target cells. Twelve clinical isolates of H. pylori were used in this study. We evaluated the effects of rebamipide and ecabet sodium, individually and in combination, on H. pylori adhesion to target cells quantitatively using our previously established enzyme-linked immunosorbent assay. Rebamipide and ecabet sodium each partially inhibited H. pylori adhesion. In contrast, adhesion was almost completely inhibited by pretreating target cells and H. pylori with the combination of rebamipide and ecabet sodium. Our studies suggest that the synergistic antiadhesion activity of rebamipide and ecabet sodium is greater than that of each antiulcer agent alone.

AB - Helicobacter pylori is a major etiological agent in gastroduodenal disorders. The adhesion of H. pylori to gastric epithelial cells is the initial step of H. pylori infection. Inhibition of H. pylori adhesion is thus a therapeutic target in the prevention of H. pylori infection. We have reported that rebamipide and ecabet sodium, mucoprotective antiulcer agents, independently inhibit H. pylori adhesion. However, the antiadhesion activity of each antiulcer agent was incomplete. Experiments were performed to evaluate the combined effect of rebamipide and ecabet sodium on H. pylori adhesion to gastric epithelial cells. MKN-28 and MKN-45 cells, derived from human gastric carcinomas, were used as target cells. Twelve clinical isolates of H. pylori were used in this study. We evaluated the effects of rebamipide and ecabet sodium, individually and in combination, on H. pylori adhesion to target cells quantitatively using our previously established enzyme-linked immunosorbent assay. Rebamipide and ecabet sodium each partially inhibited H. pylori adhesion. In contrast, adhesion was almost completely inhibited by pretreating target cells and H. pylori with the combination of rebamipide and ecabet sodium. Our studies suggest that the synergistic antiadhesion activity of rebamipide and ecabet sodium is greater than that of each antiulcer agent alone.

KW - Combination

KW - Ecabet sodium

KW - Helicobacter pylori adhesion

KW - Rebamipide

UR - http://www.scopus.com/inward/record.url?scp=0033926198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033926198&partnerID=8YFLogxK

M3 - Article

C2 - 10981828

AN - SCOPUS:0033926198

VL - 44

SP - 557

EP - 562

JO - Microbiology and Immunology

JF - Microbiology and Immunology

SN - 0385-5600

IS - 7

ER -